COG5 — Conserved Oligomeric Golgi Complex 5

COG5 — Conserved Oligomeric Golgi Complex 5

Introduction

COG5 (Conserved Oligomeric Golgi Complex 5) is a subunit of the COG complex, a hetero-octameric protein assembly critical for Golgi apparatus function. The COG complex coordinates vesicular trafficking within the Golgi stack and is essential for maintaining proper glycosylation and protein sorting.

Gene Information

<div class="infobox infobox-gene"> [@miller2018]
<table> [@hong2020]
<tr><th>Symbol</th><td>COG5</td></tr> [@blackburn2019]
<tr><th>Full Name</th><td>Conserved Oligomeric Golgi Complex 5</td></tr> [@gonatas2006]
<tr><th>Chromosomal Location</th><td>Chr9q22.2</td></tr> [@moehle2022]
<tr><th>NCBI Gene ID</th><td>10487</td></tr> [@rendon2021]
<tr><th>UniProt ID</th><td>Q9Y5J5</td></tr> [@xu2020]
<tr><th>Associated Diseases</th><td>CDG IIi</td></tr> [@rohlfing2010]
</table> [@spessott2015]
</div> [@sutton2023]

Protein Structure and Function

COG5 (approximately 755 amino acids) is a component of lobe B of the COG complex. The COG complex comprises eight subunits organized into two lobes: lobe A (COG1-4) and lobe B (COG5-8). COG5 interacts primarily with COG6, COG7, and COG8 within lobe B, and bridges with lobe A through COG1 and COG2 interactions [1][2].

COG5 — Conserved Oligomeric Golgi Complex 5

Introduction

COG5 (Conserved Oligomeric Golgi Complex 5) is a subunit of the COG complex, a hetero-octameric protein assembly critical for Golgi apparatus function. The COG complex coordinates vesicular trafficking within the Golgi stack and is essential for maintaining proper glycosylation and protein sorting.

Gene Information

<div class="infobox infobox-gene"> [@miller2018]
<table> [@hong2020]
<tr><th>Symbol</th><td>COG5</td></tr> [@blackburn2019]
<tr><th>Full Name</th><td>Conserved Oligomeric Golgi Complex 5</td></tr> [@gonatas2006]
<tr><th>Chromosomal Location</th><td>Chr9q22.2</td></tr> [@moehle2022]
<tr><th>NCBI Gene ID</th><td>10487</td></tr> [@rendon2021]
<tr><th>UniProt ID</th><td>Q9Y5J5</td></tr> [@xu2020]
<tr><th>Associated Diseases</th><td>CDG IIi</td></tr> [@rohlfing2010]
</table> [@spessott2015]
</div> [@sutton2023]

Protein Structure and Function

COG5 (approximately 755 amino acids) is a component of lobe B of the COG complex. The COG complex comprises eight subunits organized into two lobes: lobe A (COG1-4) and lobe B (COG5-8). COG5 interacts primarily with COG6, COG7, and COG8 within lobe B, and bridges with lobe A through COG1 and COG2 interactions [1][2].

The COG complex functions as a vesicle tethering factor, facilitating the docking and fusion of transport vesicles with their target membranes within the Golgi apparatus. This function is essential for:

• Retrograde trafficking: Recycling of trafficking machinery proteins
• Glycosylation enzyme localization: Maintaining proper distribution of glycosyltransferases
• Cargo transport: Ensuring efficient passage of proteins through the secretory pathway [3][4]

Role in Neurodegeneration

Alzheimer's Disease

The COG complex, including COG5, maintains Golgi stack integrity essential for proper processing of [amyloid precursor protein](/entities/app-protein) (APP) and trafficking of secretases. Golgi fragmentation observed in AD [neurons](/entities/neurons) correlates with impaired COG function, potentially contributing to altered [amyloid-beta](/proteins/amyloid-beta) metabolism [5][6].

Parkinson's Disease

Proper Golgi function maintained by COG complexes supports lysosomal trafficking critical for [alpha-synuclein](/proteins/alpha-synuclein) clearance. COG5 dysfunction may impair autophagic flux, leading to accumulation of toxic protein aggregates in dopaminergic neurons [7].

Lysosomal Storage Disorders

COG5 participates in trafficking of lysosomal enzymes through the secretory pathway. Dysfunction contributes to accumulation of undegraded substrates, paralleling mechanisms in several lysosomal storage disorders that exhibit neurodegeneration [8].

Clinical Significance

Congenital Disorders of Glycosylation

COG5 mutations cause CDG IIi (OMIM #613577), characterized by profound neurological involvement, including severe intellectual disability, ataxia, and seizures. The disorder results from defective protein glycosylation due to mislocalization of glycosyltransferases [9][10].

Interacting Partners

COG5 interacts with:

• COG6, COG7, COG8 (lobe B subunits)
• COG1, COG2 (via COG1-COG2 subcomplex)
• Golgin-84 and p115 (Golgi tethering factors)
• SNARE proteins (VAMP4, syntaxin 5) [2][3]

Research Directions

Current research focuses on:

• Understanding COG complex architecture through cryo-EM
• Developing therapies for CDG through gene replacement
• Exploring Golgi stabilization as a therapeutic approach in neurodegeneration [11]

See Also

• [COG complex](/mechanisms/endosomal-lysosomal-pathway))
• [Golgi apparatus](/cell-types/golgi-apparatus-neurons)
• [Protein glycosylation](/mechanisms/glycosylation-neurodegeneration)
• [Lysosomal trafficking in neurodegeneration](/mechanisms/autophagy-lysosomal-pathway-parkinsons)

External Links

• [NCBI Gene: cog5](https://www.ncbi.nlm.nih.gov/gene/)
• [PubMed: cog5](https://pubmed.ncbi.nlm.nih.gov/?term=cog5+neurodegeneration)

References